Four-Supplement Combo Extends Mouse Lifespan by 33% Starting in Old Age

Extending healthy lifespan through targeted supplementation is one of the most pursued goals in longevity science. A new study shared by aging researcher João Pedro de Magalhães offers a striking data point: a four-compound oral regimen extended median remaining lifespan in mice by 33%, even when initiated in old age and against the backdrop of an unhealthy diet.

The intervention combined quercetin, a well-characterized senolytic that selectively eliminates damaged senescent cells; nicotinamide riboside (NR), a NAD+ precursor that supports cellular energy metabolism; urolithin A, a gut-derived metabolite that activates mitophagy and improves mitochondrial quality control; and alpha-lipoic acid, a potent antioxidant involved in mitochondrial energy production. Each agent addresses a distinct hallmark of aging, making the combination a multi-target approach.

Critically, the mice were fed a high-fat Western diet — a model of metabolic stress and obesity-related aging — and treatment began at 18 months, an age corresponding to late middle age or early old age in humans. The 33% extension in median remaining lifespan under these conditions is a meaningful result, suggesting the combination may be effective even in suboptimal metabolic contexts.

For clinicians and health-conscious individuals, the findings are intriguing because all four compounds are currently available as supplements and are already in widespread use. The multi-mechanism design aligns with emerging consensus that single-target interventions may be insufficient to meaningfully slow aging.

However, significant caution is warranted. This is a mouse study, and lifespan results in rodents have historically failed to translate directly to humans. The summary is based on a tweet and abstract only, and full methodology, dosing details, and statistical rigor cannot be assessed. Human clinical trials are needed before any therapeutic recommendations can be made.